Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

April 27, 2004; 62 (8) Patient Page

Does the percutaneous closure of patent foramen ovale help the migraine sufferer?

Pranathi Kondapaneni
First published April 26, 2004, DOI: https://doi.org/10.1212/WNL.62.8.E20
Pranathi Kondapaneni
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Does the percutaneous closure of patent foramen ovale help the migraine sufferer?
Pranathi Kondapaneni
Neurology Apr 2004, 62 (8) E20-E21; DOI: 10.1212/WNL.62.8.E20

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
2019

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Patient Page

What is a migraine?

A migraine is a chronic episodic headache condition associated with other symptoms such as nausea/vomiting and sound/light sensitivity. Migraines can be classified into two types: with aura and without aura. An aura is a neurological warning symptom that precedes the headache. More information about migraine headache can be found on the next page.

What is a patent foramen ovale (PFO)?

The heart’s right side receives blood that does not contain much oxygen and pumps the blood into the lungs to get oxygen. Then the blood goes through the heart’s left side to get to the brain and other organs of the body. A patent foramen ovale (PFO) is a persistent hole in the heart’s right/left wall boundary that did not close after birth. This opening can cause blood in the right side of the heart to move into the left side of the heart before it has had a chance to get oxygen from the lungs. When this happens, the rest of the body does not get as much oxygen as it should. It is possible that blood clots can pass through this hole and lead to stroke. The figure shows what this looks like.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure. Diagram of patent foramen ovale (the hole in the “atrial septum”).

How is a PFO related to migraine?

Research has shown that patients who have a PFO also have migraine more often than people without a PFO. Why might this be? It is possible that blood without enough oxygen may trigger a migraine when it reaches the brain. In this issue of Neurology,two groups of researchers from Belgium and Switzerland studied whether percutaneous closure (closing the PFO by a technique that does not require a major surgical procedure) would lead to fewer migraines.

The Belgian group gave a questionnaire about migraines to people after they had the PFO closure.1 The Swiss group gave a questionnaire assessing the headache frequency and characteristics for the year before and after the PFO closure.2 There was no appreciable affect on the non-migraine headache patients. In both studies, the PFO closure was done because doctors suspected that a blood clot passing through the PFO might have caused a stroke. The frequency of migraine was decreased in both studies after PFO closure. Only the Swiss study evaluated both migraine and non-migraine headaches. More information about the effectiveness of PFO closure and headaches from these two studies can be found in the table.

View this table:
  • View inline
  • View popup

What do these studies mean?

These studies add to the growing body of evidence that there is an association between a PFO and migraine. First, the number of people who had migraine with aura in both studies was higher than in the general population. Second, PFO closure was associated with reduction of migraine symptoms in patients having migraine both with and without aura. Third, in the second study, non-migraine headaches were not affected by PFO closure.

These studies are important in that they hold a clue to a potentially correctable trigger of migraine. However, they do not support PFO closure as a treatment for migraine because of two major limitations: (1) the studies were retrospective (they asked patients for information about their headaches that occurred in the past); and (2) they studied only stroke patients. To get better results, a study is needed that evaluates otherwise healthy migraine patients and collects information in real time (prospectively).

Currently, the treatment standard for migraine includes medications and lifestyle modification. However, more research may help uncover some of the mechanisms behind the migraine and yield future remedies.

ABOUT MIGRAINE

What is a migraine headache?

A migraine is a recurring, throbbing headache. It usually occurs on one side of the head. While it is much more common in young women, it can strike anyone, at any age. It often runs in families.

What causes migraine?

The exact cause of migraine is unknown. During an attack, changes in brain activity may cause blood vessels and nerves around the brain to become inflamed. Many women have attacks linked to their menstrual cycles.

What are the symptoms of migraine headache?

People with migraines may have very different symptoms, which can include:

  • Moderate to severe headache that lasts 4 to 72 hours

  • Throbbing pain, often on one side of the head

  • Increased pain after exercise or movement

  • Sensitivity to bright light, sound, or odors

  • Nausea or vomiting with the headache

One in five people with migraine have a warning before the headache. This is called an aura. You may see flashing lights, temporarily lose your sight, or go numb on one side of your body.

How is migraine diagnosed?

No medical test can tell you if you have migraine. You will need to provide details about your headache to your neurologist. Your doctor will also do a neurological exam. Often, no further testing is needed.

How is migraine treated?

Although there is no cure, migraine is treatable with medications, stress management techniques and a healthy lifestyle. Most people with migraine can find relief using some of the treatment approaches described below. Talk to your doctor about which treatment is best for you. Keeping a headache diary is a valuable tool for treating migraine. It will help you work with your neurologist to identify triggers and track how medical and nonmedical interventions are working.

What are some of the things I can do other than taking medicine to treat my migraine?

There are many ways to reduce the impact migraine has on your life.

Know and avoid your migraine triggers, which may include:

  • Diet:Missed meals, alcohol (especially red wine), foods with monosodium glutamate (MSG), excessive caffeine, and meats preserved with nitrates and nitrites

  • Sleep:Too much or too little sleep

  • Stress: Stress and release from stress

  • Environmental factors: Weather change, glaring or fluorescent lights, strong odors, and high altitude

Research has shown that some cognitive and behavioral treatments can help prevent migraine:

  • Relaxation training

  • Thermal biofeedback with relaxation training

  • Electromyographic biofeedback

  • Cognitive-behavioral therapy (also called stress-management training)

Medicines to treat the headache right after it has started

Acute, or immediate, treatments are used to stop an attack when it occurs or to treat its symptoms. These are listed below. Overuse of acute drugs can lead to a daily migraine-like headache, called a rebound headache.

  • Nonprescription (over-the-counter) medications, such as aspirin, ibuprofen or acetaminophen combined with aspirin and caffeine

  • Prescription nonsteroidal anti-inflammatory drugs and analgesics

  • Specific drugs used to stop migraine attacks such as triptans and ergot alkaloids

Medicines to prevent migraine

Daily preventive medications are available for people with frequent, debilitating headaches:

  • Antidepressants

  • β-Blockers

  • Calcium channel blockers

  • Medicines also used to treat epilepsy

  • Alternative treatments such as vitamin B2, magnesium, and feverfew

For more information

American Academy of Neurology

Education & Research Foundation

651-695-2712

www.thebrainmatters.org

American Council for Headache Education

856-423-0258

www.achenet.org

American Headache Society

856-423-0043

www.ahsnet.org

National Headache Foundation

888-NHF-5552

www.headaches.org

References

  1. ↵
    Post MC, Thijs V, Herroelen L, Budts WIHL. Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine. Neurology. 2004: 62: 1439–1440.
    OpenUrlFREE Full Text
  2. ↵
    Schwerzmann M, Wiher S, Nedeltchev K, et al. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology. 2004: 62: 1399–1401.
    OpenUrlAbstract/FREE Full Text

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Patient Page
    • ABOUT MIGRAINE
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study

Dr. Robert Shapiro and Dr. Amynah Pradhan

► Watch

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published
Neurology: 100 (4)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise